Vascular endothelial growth factor C: the predicator of early recurrence in patients with N2 non-small-cell lung cancer

European Journal of Cardio-thoracic Surgery

Volumn 37, Issue 3, 2010, Pages 546-551

  Chen, Gang ^a   Liu, Xiang yan ^a   Wang, Zhou ^a   Liu, Fan ying ^a  

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Carcinoma; Early recurrence; Lymph node metastasis; Non small cell lung; RT PCR; VEGF C

Indexed keywords

VASCULOTROPIN C;

ADULT; ARTICLE; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; FEMALE; HAZARD RATIO; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG DISEASE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; BRAIN NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RADIOTHERAPY, ADJUVANT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 76449093747     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2009.08.005     Document Type: Article

References (15)

1. Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., Saksela O., Kalkkinen N., and Alitalo K. A novel endothelial growth factor, VEGF-C, is a ligand for the Flt4(VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 15 (1996) 290-298
2. Paavonen K., Horelli-Kuitunen N., Chilov D., Kukk E., Pennanen S., Kallioniemi O.P., Pajusola K., Olofsson B., Eriksson U., Joukov V., Palotie A., and Alitalo K. Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively. Circulation 93 (1996) 1079-1082
3. Mandriota S.J., Jussila L., Jeltsch M., Compagni A., Baetens D., Prevo R., Banerji S., Huarte J., Montesano R., Jackson D.G., Orci L., Alitalo K., Christofori G., and Pepper M.S. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 20 (2001) 672-682
4. Naruke T., Suematu K., and Ishikawa S. Lymph node mapping and curability at various levels of metastasis in resected lung cancer. J Thorac Cardiovasc Surg 76 (1978) 832-839
5. Liu X.E., Sun X.D., and Wu J.M. Expression and significance of VEGF-C and FLT-4 in gastric cancer. World J Gastroenterol 10 (2004) 352-355
6. Noda E., Maeda K., Inoue T., Nishihara T., Nishiguchi Y., Ohira M., and Hirakawa K. Predictive value of vascular endothelial growth factor-C expression for local recurrence of rectal carcinoma. Oncol Rep 17 (2007) 1327-1331
7. Saintigny P., Kambouchner M., Ly M., Gomes N., Sainte-Catherine O., Vassy R., Czernichow S., Letoumelin P., Breau J.L., Bernaudin J.F., and Kraemer M. Vascular endothelial growth factor-C and its receptor VEGFR-3 in non-small-cell lung cancer: concurrent expression in cancer cells from primary tumour and metastatic lymph node. Lung Cancer 58 2 (2007) 205-213
8. Tsukioka T., Nishiyama N., Iwata T., Izumi N., Mizuguchi S., Morita R., Inoue K., and Suehiro S. Early recurrence of completely resected N2-positive non-small-cell lung cancer. Gen Thorac Cardiovasc Surg 55 (2007) 113-118
9. Ichinose Y., Kato H., Koike T., Tsuchiya R., Fujisawa T., Shimizu N., Watanabe Y., Mitsudomi T., Yoshimura M., and Japan Clinical Oncology Group. Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials. Lung Cancer 34 (2001) 29-36
10. Martini N., Rusch V.W., Bains M.S., Kris M.G., Downey R.J., Flehinger B.J., and Ginsberg R.J. Factors influencing ten-year survival in resected stages I to IIIa non-small cell lung cancer. J Thorac Cardiovasc Surg 117 (1999) 32-36
11. Choi Y.S., Shim Y.M., Kim J., and Kim K. Recurrence-free survival and prognostic factors in resected pN2 non-small cell lung cancer. Eur J Cardiothorac Surg 22 (2002) 695-700
12. Andre F., Grunenwald D., Pujol J.L., Girard P., Dujon A., Brouchet L., Brichon P.Y., Westeel V., and Le Chevalier T. Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be reconsidered?. Cancer 91 (2001) 2394-2400
13. Padera T.P., Kadambi A., di Tomaso E., Carreira C.M., Brown E.B., Boucher Y., Choi N.C., Mathisen D., Wain J., Mark E.J., Munn L.L., and Jain R.K. Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296 (2002) 1883-1886
14. Hoshida T., Isaka N., Hagendoorn J., di Tomaso E., Chen Y.L., Pytowski B., Fukumura D., Padera T.P., and Jain R.K. Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications. Cancer Res 66 (2006) 8065-8075
15. Hirakawa S., Brown L.F., Kodama S., Paavonen K., Alitalo K., and Detmar M. VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites. Blood 109 (2007) 1010-1017